211 related articles for article (PubMed ID: 1301849)
21. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
22. Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC.
Ytterberg SR; Huard TK; Schnitzer TJ
J Rheumatol; 1983 Dec; 10(6):906-12. PubMed ID: 6663595
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
Ytterberg SR; Schnitzer TJ
Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601
[TBL] [Abstract][Full Text] [Related]
24. Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus.
Lin SJ; Chen JY; Kuo ML; Hsiao HS; Lee PT; Huang JL
Mediators Inflamm; 2016; 2016():9675861. PubMed ID: 27847409
[TBL] [Abstract][Full Text] [Related]
25. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
[TBL] [Abstract][Full Text] [Related]
26. Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease.
Marazuela M; Vargas JA; Alvarez-Mon M; Albarrán F; Lucas T; Durántez A
Eur J Endocrinol; 1995 Feb; 132(2):175-80. PubMed ID: 7858736
[TBL] [Abstract][Full Text] [Related]
27. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.
Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A
Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
[TBL] [Abstract][Full Text] [Related]
29. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
30. Abnormal interferon modulation of natural cytotoxicity in systemic lupus erythematosus. Relation to suppressive serum factors.
Sibbitt WL; Froelich CJ; Bankhurst AD
Arthritis Rheum; 1983 Dec; 26(12):1452-9. PubMed ID: 6651894
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of lupus erythematosus.
Błaszczyk M; Majewski S; Wasik M; Chorzelski T; Jabłonska S
Br J Dermatol; 1987 Dec; 117(6):709-14. PubMed ID: 3426951
[TBL] [Abstract][Full Text] [Related]
32. [Immunoregulatory effects of monomer T4 from Tripterygium wilfordii hook. I. Immunoregulatory effects of T4 on NK activity of mouse splenocytes].
Lou D; Xu W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Apr; 12(2):115-20. PubMed ID: 2143110
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.
Villanueva J; Lee S; Giannini EH; Graham TB; Passo MH; Filipovich A; Grom AA
Arthritis Res Ther; 2005; 7(1):R30-7. PubMed ID: 15642140
[TBL] [Abstract][Full Text] [Related]
34. The effects of general anesthesia and surgery on basal and interferon stimulated natural killer cell activity of humans.
Kutza J; Gratz I; Afshar M; Murasko DM
Anesth Analg; 1997 Oct; 85(4):918-23. PubMed ID: 9322480
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
36. Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency.
Tóth J; Starsia Z; Buc M; Stefanovic J
Immunobiology; 1989 Nov; 180(1):47-54. PubMed ID: 2625354
[TBL] [Abstract][Full Text] [Related]
37. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
Blanca I; Herberman RB; Ortaldo JR
Nat Immun Cell Growth Regul; 1985; 4(1):48-59. PubMed ID: 4033671
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
Bose A; Baral R
Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus.
Cruz-González DJ; Gómez-Martin D; Layseca-Espinosa E; Baranda L; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R; Monsiváis-Urenda AE
Clin Exp Immunol; 2018 Mar; 191(3):288-300. PubMed ID: 29058308
[TBL] [Abstract][Full Text] [Related]
40. Deficient interleukin-2-activated killer cell cytotoxicity in patients with systemic lupus erythematosus.
Froelich CJ; Guiffaut S; Sosenko M; Muth K
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):132-45. PubMed ID: 2783399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
